According to the provisions of the measures for the identification and management of Songjiang District Enterprise Technology Center, the District Economic Commission organized the 2017 annual assessment and evaluation of the district level enterprise technology center. After strict control and layer by layer screening, Biocompounds Pharmaceutical Inc. stood out among nearly 120 enterprises and became one of the few enterprises with excellent rating.
Briefing on "technological innovation" in Biocompounds Pharmaceutical Inc.
BPI is committed to the R & D, production, customization and technical services of API and advanced pharmaceutical intermediates. For more than ten years, it has focused on the field of small molecule targeted and alkaloid antitumor drugs and their intermediates. The process and quality technology platform of more than 30 kinds of small molecule targeted drugs, camptothecin alkaloids and active VD derivatives has been preliminarily formed.
Current situation and achievements of technological innovation
Obtain invention patent
BPI has a professional R & D team and R & D experience in more than 50 projects. Led by CTO, it is composed of many doctors and masters in pharmaceutical and chemical engineering with many years of rich working experience, with returnees as the core.我We have always been led by scientific and technological innovation, and have applied for 27 invention patents, of which 14 have been authorized. Since the establishment of Songjiang district level enterprise technology center in 2016, BPI has undertaken 8 R & D projects and newly applied for 7 invention patents, including 4 separate applications and 3 cooperative applications with East China Normal University.
Honorary title
BPI is a high-tech enterprise in Shanghai, a pilot enterprise of patent work in Shanghai, a station building unit of Shanghai academician and expert workstation, a cultivation enterprise of small scientific and technological giants in Shanghai and an enterprise technology center in Songjiang District. The company will strive to play a leading role in the development of industrial strategy, improve the application ability of industrial technology, enhance the innovation power of enterprises, improve the independent innovation ability of enterprises, and promote the optimization and adjustment of industrial economic layout and structure.
Improve the R & D system
The company has established R & D project management system, R & D investment management measures and R & D investment accounting management system to manage and reasonably control the budget expenditure of R & D projects. The performance appraisal method for R & D personnel has been established to make the income fluctuate with the work effect and stimulate the enthusiasm of scientific and technological talents. The internal science and technology incentive system of the company shall be formulated to encourage inventions, technological improvements and suggestions, which shall be selected by the R & D department, approved by the board of directors and rewarded annually.
Carry out innovation projects
The company has undertaken Shanghai Science and Technology Commissioner project, Shanghai / Songjiang District small and medium-sized enterprise innovation fund project, won the second prize of Songjiang District Science and technology progress award, and three products have been recognized as high-tech achievement transformation projects. In the future, with the advantages of variety, technology and quality focused on development, we will adhere to product R & D and innovation, and create a characteristic brand in the field of small molecule targeted drugs of precision medicine.
Establish a cooperation platform with colleges and Universities
It has established long-term strategic cooperation relations with scientific research institutes such as East China University of technology, East China Normal University, Shanghai University of engineering and technology and Jiangsu University, flexibly opened up channels for industry university research cooperation, reduced R & D costs, accelerated progress, and formed systematic and platform products in a short time.
Prospect of future technical work
The company will strive to play a leading role in the development of industrial strategy, improve the application ability of industrial technology, enhance the innovation power of enterprises, improve the independent innovation ability of enterprises, and promote the optimization and adjustment of industrial economic layout and structure. In the key supporting field of biomedicine, we will further explore the market of small molecule targeted APIs and intermediates, and continue to track the technological development frontier in this field. In the next step, BPI enterprise technology center will continue to carry out the research and development of process technology and quality control of small molecule targeted drug innovation and creation platform, and focus on forming new processes and products with easy availability of raw materials, simple process, economic and environmental protection, cost and quality advantages, so as to realize further industrialized production.
